“Max will use his experience in elite sport and medicine to help the team move forward,”
Lidl-Trek said. “There he can put the knowledge he has gained into practice and utilize his academic background.”
Walscheid's decade-long career included 14 wins
Taking 14 wins during his career, he impressively tasted victory at the ZLM Tour earlier this month. However, he admitted that saying goodbye to the sport that shaped him will be a difficult transition.
“I believe that cycling has shaped me, and I will never let go of this part of myself,” Walscheid said.
“Working in a top-level sports environment with opportunities to test and optimize is something I find incredibly interesting. Saying goodbye to something you are so passionate about is never easy. It hurts, but this is the perfect moment to say goodbye.”
Walscheid will continue his medical training while transitioning into the role and admitted his gratitude to the team.
"I am extremely grateful to Lidl-Trek for allowing me to continue working with the team in our performance department. While I complete my medical training, I will soon be working behind the scenes, and I am really looking forward to it."
Combining racing knowledge and medical experience
CEO Andy Schleck hopes his racing experience and medical background can make the perfect combination for the role: “What makes him suitable for this new role is the combination of his racing experience and medical background. He knows what a rider goes through, and his medical training gives him the tools to understand why. We are happy that we can retain that perspective within the team.”
The departure means that the team currently has 29 riders confirmed for 2027 already, with reports indicating that the team was already over their maximum of 30 riders for the season.
UCI regulations stipulate that a WorldTour team can have a maximum of thirty riders under contract, provided that two neo-pros are among them.